Does leukotriene modulation of eosinophil function explain the therapeutic effectiveness of receptor antagonists in some patients with asthma?

Clinical and Experimental Allergy

Volumn 31, Issue 6, 2001, Pages 806-807

  Busse, William W ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CD69 ANTIGEN; CHEMOKINE; CYTOKINE; ENZYME INHIBITOR; EOTAXIN; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOTRIENE; MONTELUKAST; PRANLUKAST; RANTES; RECEPTOR BLOCKING AGENT; THROMBOCYTE ACTIVATING FACTOR; VASCULAR CELL ADHESION MOLECULE 1; ZILEUTON;

AIRWAY; ALLERGY; ANTIGEN EXPRESSION; ASTHMA; BONE MARROW CELL; BRONCHOSCOPY; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CONCENTRATION (PARAMETERS); DRUG MECHANISM; EDITORIAL; ENDOTHELIUM; ENDOTHELIUM CELL; EOSINOPHIL; EOSINOPHILIA; GUINEA PIG; HUMAN; INFLAMMATION; LUNG BLOOD VESSEL; MEDICAL LITERATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; RECEPTOR BLOCKING; SMOOTH MUSCLE CONTRACTION; UMBILICAL VEIN;

ACETATES; ANTI-ASTHMATIC AGENTS; ASTHMA; ENDOTHELIUM, VASCULAR; EOSINOPHILS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; QUINOLINES; TREATMENT OUTCOME;

EID: 0035723490     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01144.x     Document Type: Editorial

References (18)

1. Effects of a specific cysteinyl leukotrienereceptor antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells
2. Leukotriene E4 and granulocytic infiltration into asthmatic airways
3. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge
4. Relationship of cellular transmigration and airway response after allergen challenge
5. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
6. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma
7. Effect of 5-1ipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma
8. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
9. Eosinophilia
10. Chemokines and IL-5: Major players of eosinophil recruitment in asthma
11. IL-5 increases expression of 5-1ipoxygenase-activating protein and translocates 5-1ipoxygenase to the nucleus in human blood eosinophils
12. Persistent airway eosinophilia after leukotriene (LT)D-4 administration in the guinea pig - Modulation by the LTD(4) receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody
13. Chemokines and allergic disease
14. Chemokines - Chemotactic cytokines that mediate inflammation
15. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm
16. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells
17. The effect of transendothelial migration on eosinophil function
18. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals